Oral Oncology
Volume 39, Issue 5 , Pages 445-452 , July 2003

Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells

  • R. Fujimoto

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, School of Dentistry, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770 8504, Japan
    • ,
  • N. Kamata

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, School of Dentistry, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770 8504, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-88-633-7352; fax: +81-88-633-7388
    • ,
  • M. Taki

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, School of Dentistry, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770 8504, Japan
    • ,
  • K. Yokoyama

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, School of Dentistry, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770 8504, Japan
    • ,
  • M. Tomonari

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, School of Dentistry, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770 8504, Japan
    • ,
  • M. Nagayama

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, School of Dentistry, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770 8504, Japan
    • ,
  • S. Yasumoto

      Affiliations

    • Laboratory of Molecular Cell Biology, Kanagawa Cancer Center Research Institute, Yokohama, Japan

Received 18 November 2002 ,Accepted 13 December 2002.

References 

  1. Greider CW. Telomere length regulation. Annual Review of Biochemistry. 1996;65:337–365
  2. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al.  Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015
  3. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997;90:785–795
  4. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, et al.  Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277:955–959
  5. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 1998;18:65–68
  6. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, et al.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997;12:2011–2019
  7. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998;58:4168–4172
  8. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, et al.  Direct activation of TERT transcription by c-MYC. Nat Genet. 1999;21:220–224
  9. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 1999;18:1219–1226
  10. Ayer DE, Kretzner L, Eisenman RN. Mad (a heterodimeric partner for Max that antagonizes Myc transcriptional activity). Cell. 1993;72:211–222
  11. Zervos AS, Gyuris J, Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 1993;72:223–232
  12. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, et al.  A human telomeric protein. Science. 1995;270:1663–1667
  13. Broccoli D, Smogorzewska A, Chong L, de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet. 1997;17:231–235
  14. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat Genet. 1997;17:236–239
  15. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 1997;385:740–743
  16. Bianchi A, Smith S, Chong L, Elias P, de Lange T. TRF1 is a dimer and bends telomeric DNA. EMBO J. 1997;16:1785–1794
  17. Griffith J, Bianchi A, de Lange T. TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol. 1998;278:79–88
  18. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, et al.  Mammalian telomeres end in a large duplex loop. Cell. 1999;97:503–514
  19. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 1998;92:401–413
  20. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 1999;283:1321–1325
  21. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA. 1994;91:2900–2904
  22. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315–2320
  23. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA. 1996;89:10114–10118
  24. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, et al.  Telomerase activity in normal human epithelial cells. Oncogene. 1996;13:433–439
  25. Kunimura C, Kikuchi K, Ahmed N, Shimizu A, Yasumoto S. Telomerase activity in a specific cell subset co-expressing integrin beta1/EGFR but not p75NGFR/bcl2/integrin beta4 in normal human epithelial cells. Oncogene. 1998;17:187–197
  26. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res. 1997;57:610–614
  27. Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H, Ueda N. Telomerase component as a diagnostic tool in human oral lesions. Int J Cancer. 1999;80:801–804
  28. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, et al.  Expression of TERT in early premalignant lesions and a subset of cells in normal tissue. Nat Genet. 1998;19:182–186
  29. Fujimoto R, Kamata N, Yokoyama K, Ueda N, Satomura K, Hayashi E, et al.  Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol. 2001;37:132–140
  30. Apiwat M, Pakpoom S, Saengsoon T, Virote S, Anavaj S, Saowanee Y, et al.  Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res. 1996;56:3530–3533
  31. Miyoshi Y, Tsukinoki K, Imaizumi T, Yamada Y, Ishizaki K, Watanabe Y, et al.  Telomerase activity in oral cancer. Oral Oncol. 1999;35:283–289
  32. Kamata N, Yokoyama K, Fujimoto R, Ueda N, Hayashi E, Nakanishi H, et al.  Growth of normal oral keratinocytes and squamous cell carcinoma cells in a novel protein-free defined medium. In Vitro Cell Dev Biol Anim. 1999;35:635–641
  33. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R, et al.  Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol. 2001;37:65–71
  34. Yasumoto S, Taniguchi A, Sohma K. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line (functional role of EGF-responsive silencer in the HPV-16 long control region). J Virol. 1991;65:2000–2009
  35. Hashida T, Yasumoto S. Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene. J Gen Virol. 1991;72:1569–1577
  36. Pirisi L, Yasumoto S, Feller M, Doniger J, DiPaolo JA. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol. 1987;61(4):1061–1066
  37. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 1997;17:498–502
  38. Yi X, White DM, Aisner DL, Baur JA, Wright WE, Shay JW. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia. 2000;2:433–440
  39. Suwa T, Yang L, Hornsby PJ. Telomerase activity in primary cultures of normal adrenocortical cells. J Endocrinol. 2001;170:677–684
  40. Yamada K, Yajima T, Yagihashi A, Kobayashi D, Koyanagi Y, Asanuma K, et al.  Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells. Jpn J Cancer Res. 2000;91:1278–1284
  41. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 2002;295:2446–2449
  42. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR. The hTERT alpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia. 2000;2:426–432

PII: S1368-8375(03)00003-4

doi: 10.1016/S1368-8375(03)00003-4

Oral Oncology
Volume 39, Issue 5 , Pages 445-452 , July 2003

Article Tools

* Image Usage & Resolution